Glewis, Sarah, Alexander, Marliese, Khabib, Muhammad N. H., Brennan, Annabelle, Lazarakis, Smaro, Martin, Jennifer, Tie, Jeane, Lingaratnam, Senthil, Michael, Michael. Nature Publishing Group; 2022. A systematic review and meta-analysis of toxicity and treatment outcomes with pharmacogenetic-guided dosing compared to standard of care BSA-based fluoropyrimidine dosing.

Glewis, Sarah, Lingaratnam, Senthil, Krishnasamy, Michael, Martin, Jennifer H., Tie, Jeanne, Alexander, Marliese, Michael, Michael. Sage; 2024. Pharmacogenetics testing (DPYD and UGT1A1) for fluoropyrimidine and irinotecan in routine clinical care: Perspectives of medical oncologists and oncology pharmacists.

Glewis, Sarah, Krishnasamy, Mei, Campbell, Ian, Martin, Jennifer H., Tie, Jeanne, Alexander, Marliese, Michael, Michael, Lingaratnam, Senthil, Harris, Sam, Underhill, Craig, Georgiou, Chloe, Warren, Mark, Campbell, Robert, IJzerman, Maarten, Fagery, Mussab. Wiley-Blackwell; 2023. Patient and health care professional acceptability of pharmacogenetic screening for DPYD and UGT1A1: a cross sectional survey..